UNITED STATES
SECURITIES & EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
Moore Medical Corp.
(Name of Issuer)
615799103
Common Stock
(Title of Class of Securities)
(CUSIP Number)
Michael Emanuel, Esq.
c/o Loeb Partners Corporation
61 Broadway, N.Y., N.Y., 10006 (212) 483-7047
(Name, address and Telephone Number of Person Authorized to Receive Notices
and Communications)
March 1, 2004
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. Check
the following box if a fee is being paid with statement [ ]. (A fee is not
required only if the following reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described is Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.) Note: Six copies of this statement, including all exhibits,
should be filed with the Commission. See Rule 13d-1(a) for other parties to whom
copies are to be sent. *The remainder of this cover page shall be filled out for
a reporting person's initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page. The information
required on the remained of this cover page shall not be deemed to be "filed"
for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13D
CUSIP NO. 615799103
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Loeb Partners Corporation
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
3 SEC USE ONLY
4 SOURCE OF FUNDS*
WC, O
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED [ ]
PURSUANT TO ITEMS 2(d) or 2(e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF 7 SOLE VOTING POWER
SHARES 9,870 Shares of Common stock
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY 5,922 Shares of Common stock
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 9,870 Shares of Common stock
PERSON WITH 10 SHARED DISPOSITIVE POWER
5,922 Shares of Common stock
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
15,792 Shares of Common stock
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.5%
14 TYPE OF REPORTING PERSON*
PN, BD, IA
SCHEDULE 13D
CUSIP NO. 615799103
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Loeb Arbitrage Fund
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC, O
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED [ ]
PURSUANT TO ITEMS 2(d) or 2(e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
NUMBER OF 7 SOLE VOTING POWER
SHARES 166,803 Shares of Common stock
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY -----
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 166,803 Shares of Common stock
PERSON WITH 10 SHARED DISPOSITIVE POWER
-----
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
166,803 Shares of Common stock
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.21%
14 TYPE OF REPORTING PERSON*
PN, BD
SCHEDULE 13D
CUSIP NO. 615799103
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Loeb Offshore Fund, Ltd.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
3 SEC USE ONLY
4 SOURCE OF FUNDS*
WC, O
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED [ ]
PURSUANT TO ITEMS 2(d) or 2(e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF 7 SOLE VOTING POWER
SHARES 14,805 Shares of Common stock
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY --------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 14,805 Shares of Common stock
PERSON WITH 10 SHARED DISPOSITIVE POWER
-------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,805 Shares of Common stock
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.46%
14 TYPE OF REPORTING PERSON*
CO
Item 1. Security and Issuer.
------ -------------------
This statement refers to the Common Stock of Moore Medical Corp., 389 John
Downey Drive, P.O. Box 1500, New Britain, CT., 06050.
Item 2. Identity and Background.
------ -----------------------
No change.
Item 3. Source and Amount of Funds or Other Compensation.
------ ------------------------------------------------
No change.
Item 4. Purpose of Transaction.
------ ----------------------
No change.
Item 5. Interest in Securities of the Issuer.
------ ------------------------------------
(a) The persons reporting hereby owned the following shares of
Common Stock as of March 1, 2004.
Shares of Common Stock
Loeb Arbitrage Fund 166,803
Loeb Partners Corporation* 15,792
Loeb Offshore Fund 14,805
--------------
197,400
The total shares of Common Stock constitute 6.17% the 3,200,009 outstanding
shares of Common Stock as reported by the issuer.
-------------------------
*Including 5,922 shares of Common Stock held for the account of one customer of
Loeb Partners Corporation as to which it has investment discretion.
(b) See paragraph (a) above.
(c) The following purchases of Common Stock have been made in the last sixty
(60) days by the following:
Purchases of Common Stock
Holder Date Shares Average Price
Loeb Partners Corp.* 01-22-04 479 $13.52
01-23-04 2138 14.74
01-23-04 3266 14.74
01-28-04 899 14.73
01-29-04 2063 14.73
02-03-04 639 14.65
02-03-04 640 14.64
02-04-04 1650 14.67
02-05-04 2475 14.53
02-05-04 4125 14.53
02-06-04 107 14.52
02-06-04 825 14.49
02-11-04 825 13.54
Holder Shares Average Price
Loeb Arbitrage Fund 01-22-04 4871 13.523
01-23-04 420 14.723
01-23-04 54599 14.742
01-28-04 9156 14.733
01-29-04 20999 14.733
02-03-04 6468 14.663
02-03-04 6551 14.626
02-04-04 16800 14.673
02-05-04 25200 14.528
02-05-04 42000 14.525
02-06-04 1092 15.523
02-06-04 8400 14.493
02-11-04 8400 13.543
Holder Shares Average Price
Loeb Offshore Fund 01-22-04 450 13.52
01-23-04 39 14.74
01-23-04 5038 14.74
01-28-04 845 14.73
01-29-04 1938 14.73
02-03-04 605 14.65
02-03-04 597 14.64
02-04-04 1550 14.67
02-05-04 2325 14.53
02-05-04 3875 14.53
02-06-04 101 14.52
02-06-04 775 14.49
02-11-04 775 13.54
Sales of Common Stock
Holder Date Shares Average Price
Loeb Partners Corp.* 02-20-04 325 $11.98
02-20-04 278 11.98
02-26-04 992 12.27
02-27-04 1072 12.22
02-27-04 72 12.39
03-01-04 1600 12.00
Loeb Arbitrage Fund 02-20-04 1932 $11.977
02-20-04 4199 11.977
02-26-04 3039 12.266
02-27-04 11323 12.221
02-27-04 760 12.390
03-01-04 16900 11.998
Loeb Offshore Fund 02-20-04 178 11.98
2-20-040 388 11.98
02-26-04 969 12.27
02-27-04 1005 12.22
02-27-04 68 12.39
03-01-04 1500 12.00
-------------------
*Including 2,009 Shares of Common Stock sold for the account of one customer of
Loeb Partners Corporation as to which it has investment discretion.
All reported transactions were effected on the American Stock Exchange.
(d) Not applicable.
(e). Not applicable.
Item 6.Contracts, Arrangements, Understandings or Relationships with Respect to
the Issuer.
None.
Item 7. Materials to be Filed as Exhibits.
None.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
March 5, 2004 Loeb Partners Corporation
By: /s/ Gideon J. King,Executive Vice President
March 5, 2004 Loeb Arbitrage Fund
By: Loeb Arbitrage Management, Inc.
By: /s/ Gideon J. King, President
March 5, 2004 Loeb Offshore Fund
By: /s/ Gideon J. King, Director